Quantcast

Latest Cholangiocarcinoma Stories

2010-07-14 13:12:22

Pancreatic cancer is one of the most challenging tumors to treat. Identifying patients who have more aggressive disease could better inform treatment decisions and predict survival prognosis. A new finding from scientists at UNC Lineberger Comprehensive Cancer Center may help. The team analyzed gene profiles of pancreatic tumors from patients with both localized and metastasized disease. They identified a six-gene "signature" associated with metastatic disease. Their study is the first to...

2010-07-07 14:48:03

Intrahepatic cholangiocarcinoma (ICC) is a cancer of the bile duct in the liver. The clear cell subtype of ICC is a rare cancer; until now, only 8 cases have been reported. The number of reports is so small that a detail description of clear cell ICC is valuable. A case report will be published on May 28, 2010 in the World Journal of Gastroenterology addresses this question. The diagnostic pathology team led by Associate Professor Dr. Hayashi at the Department of Pathology, Nagasaki...

2010-07-01 14:34:31

Researchers have identified a set of "molecular signatures" for biliary atresia "“ the most common diagnosis leading to liver transplant in children "“ that can help identify the progression of disease at diagnosis and predict clinical outcomes. The Cincinnati Children's Hospital Medical Center scientists found that using traditional methods to analyze liver biopsies, only 14 of 47 infants with biliary atresia could be identified as having either inflammation or fibrosis...

2010-06-09 13:47:56

Researchers identify an enzyme important for cancer's ability to spread In collaboration with the National Cancer Centre, Singapore, Van Andel Research Institute (VARI) researchers have identified an enzyme that could help diagnose and treat cholangiocarcinoma, a form of liver cancer that strikes up to 3,000 new patients each year in the United States. Cholangiocarcinoma is the second most common type of cancer that affects the hepatobiliary system, which includes the liver, gall bladder, and...

2010-06-06 07:00:00

CHICAGO, June 6 /PRNewswire/ -- NewLink Genetics Corporation today announced positive Phase 2 clinical trial data of its HyperAcute®-Pancreas cancer immunotherapy combined with standard adjuvant chemotherapy in patients with surgically resectable pancreatic cancer. The study results suggest a potentially longer disease-free survival and one-year overall survival in this patient group than reported in previous studies of surgery and adjuvant therapy alone. These data were...

2010-05-05 12:07:21

Patients who have gastric cancer surgery followed by chemotherapy have an associated decreased risk of death and improved disease-free survival compared to patients who have surgery alone, according to an analysis of previous studies, reported in the May 5 issue of JAMA. Gastric cancer is a common and highly fatal disease, with current 5-year survival rates less than 20 percent, according to background information in the article. "Surgery for disease at an early stage can usually be performed...

2010-04-30 07:30:00

NATICK, Mass., April 30 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that multiple clinical abstracts examining the diagnostic and therapeutic utility of its SpyGlass(®) Direct Visualization System, Radial Jaw(®) 4 Biopsy Forceps and WallFlex(®) Duodenal Stent will be presented at Digestive Disease Week(®) (DDW(®)), May 1 - 5 in New Orleans. "The large number...

2010-04-16 14:01:32

Risk of non-Hodgkin lymphoma and cholangiocarcinoma in Taiwanese parous women with chronic hepatitis B virus infection New data presented today at the International Liver CongressTM 2010 found a link between chronic hepatitis B virus (HBV) and progression to cancers other than hepatocellular carcinoma. The study found that a higher risk of Non-Hodgkin Lymphoma (NHL) and Cholangiocarcinoma was associated with HBV infection in the presence of higher levels of viral replication. The data could...

2010-03-16 13:17:08

Even though older patients with colon cancer are less likely to receive chemotherapy following surgery because of concerns of adverse events, new research indicates that when they do receive this treatment, it is less toxic and of shorter duration than therapy younger patients receive, and older patients experience fewer adverse events, according to a study in the March 17 issue of JAMA, a theme issue on cancer. Study co-author Robert H. Fletcher, M.D., M.Sc., of Harvard Medical School,...

2010-03-04 07:00:00

SAN DIEGO, Calif., March 4 /PRNewswire/ -- bioTheranostics, a bioMerieux company that discovers, develops and commercializes innovative molecular diagnostic tests in oncology, announces the launch of an expanded tumor-type database for its flagship product, CancerTYPE ID®, and the launch of KRAS mutational testing. CancerTYPE ID predicts cancer origin in patients whose primary cancer was initially "unknown or uncertain" using conventional diagnostics. Knowing the site...


Latest Cholangiocarcinoma Reference Libraries

Chinese Liver Fluke, Clonorchis sinensis
2014-01-12 00:00:00

The Chinese liver fluke (Clonorchis sinensis) is a species of parasitic worm that is classified within the Platyhelminthes phylum. It can be found in Southeast Asia, Taiwan, Japan, and China and is present in nearly 30,000,000 humans today. It is thought to be one of the world’s most pervading parasites. The Chinese liver fluke requires two intermediate, or secondary, hosts and one definitive, or main, host to successfully complete its lifecycle. The first intermediate host is typically...

More Articles (1 articles) »
Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related